We are live on ! Find out more
ARTA

A.R.T. Advisors Portfolio holdings

AUM $1.79M
1-Year Est. Return 57.47%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
AUM
$2.26B
AUM Growth
+$299M
Cap. Flow
+$214M
Cap. Flow %
9.45%
Top 10 Hldgs %
6.6%
Holding
1,916
New
614
Increased
388
Reduced
316
Closed
591

Top Buys

Rank Stock Value
1
IBM icon
IBM
IBM
+$16.7M
2
NFLX icon
Netflix
NFLX
+$14.1M
3
USB icon
US Bancorp
USB
+$12.4M
4
GE icon
GE Aerospace
GE
+$11.7M
5
CHTR icon
Charter Communications
CHTR
+$11.4M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$23M
2
ABBV icon
AbbVie
ABBV
+$18.8M
3
INTU icon
Intuit
INTU
+$13.1M
4
TXN icon
Texas Instruments
TXN
+$12.6M
5
BKNG icon
Booking.com
BKNG
+$10.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 14.57%
2 Industrials 13.56%
3 Technology 13.35%
4 Healthcare 13.31%
5 Financials 12.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LTRX icon
1301
Lantronix
LTRX
$244M
$34K ﹤0.01%
17,069
+2,198
+15% +$4.45K
LUNA
1302
DELISTED
Luna Innovations Incorporated
LUNA
$33K ﹤0.01%
13,614
+500
+4% +$980
EXK
1303
Endeavour Silver
EXK
$2.35B
$30K ﹤0.01%
+12,651
New +$28.6K
TARA icon
1304
Protara Therapeutics
TARA
$227M
$29K ﹤0.01%
391
-27
-6% -$2.17K
EVOK
1305
DELISTED
Evoke Pharma
EVOK
$27K ﹤0.01%
+86
New +$35.6K
TST
1306
DELISTED
TheStreet, Inc.
TST
$27K ﹤0.01%
1,927
+505
+36% +$6.19K
ATNM icon
1307
Actinium Pharmaceuticals
ATNM
$26.8M
$26K ﹤0.01%
1,314
+314
+31% +$6.32K
OCGN icon
1308
Ocugen
OCGN
$427M
$24K ﹤0.01%
+195
New +$23.9K
PERI icon
1309
Perion Network
PERI
$371M
$23K ﹤0.01%
+7,704
New +$24.5K
TNDM icon
1310
Tandem Diabetes Care
TNDM
$1.18B
$23K ﹤0.01%
+10,019
New +$31.5K
CGRN
1311
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$22K ﹤0.01%
+2,936
New +$26.1K
REXX
1312
DELISTED
Rex Energy Corporation
REXX
$22K ﹤0.01%
+16,119
New +$30.7K
TGA
1313
DELISTED
Transglobe Energy Corp
TGA
$20K ﹤0.01%
+14,520
New +$21.5K
GAU
1314
Galiano Gold
GAU
$478M
$19K ﹤0.01%
27,263
-264,467
-91% -$214K
QUIK icon
1315
QuickLogic
QUIK
$228M
$19K ﹤0.01%
797
-2,227
-74% -$50.2K
AWSM
1316
DELISTED
Cool Holdings Inc. Common Stock
AWSM
$15K ﹤0.01%
+2,206
New +$17.4K
SCON
1317
DELISTED
Superconductor Technologies Inc.
SCON
$14K ﹤0.01%
+131
New +$14.2K
OREX
1318
DELISTED
Orexigen Therapeutics, Inc.
OREX
$13K ﹤0.01%
+10,192
New +$16.6K
EGY icon
1319
Vaalco Energy
EGY
$552M
$11K ﹤0.01%
+16,739
New +$13.1K
WRN
1320
Western Copper and Gold
WRN
$487M
$11K ﹤0.01%
+11,452
New +$11.6K
RVP icon
1321
Retractable Technologies
RVP
$20.1M
$10K ﹤0.01%
15,183
-200
-1% -$128
VGZ icon
1322
Vista Gold
VGZ
$253M
$10K ﹤0.01%
14,550
NNVC icon
1323
NanoViricides
NNVC
$35.4M
$9K ﹤0.01%
+524
New +$10.7K
AAPL icon
1324
Apple
AAPL
$4.95T
-31,600
Closed -$1.22M
ABEV icon
1325
Ambev
ABEV
$47.4B
-302,700
Closed -$1.99M

Similar funds

A.R.T. Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, A.R.T. Advisors held 1,916 positions worth $2.26B, up 15% from $1.96B the previous quarter. Its ten largest holdings account for 6.6% of the portfolio.

A.R.T. Advisors deployed $214M of net new capital in Q4 2017, opening 614 new positions and adding to 388 existing holdings. Its largest new stake was IBM: 114,615 shares worth $16.8M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was AbbVie, an estimated $18.8M trimmed.

  • A.R.T. Advisors's largest Q4 2017 buy was IBM: 114,615 shares worth $16.8M.
  • A.R.T. Advisors added most to Netflix in Q4 2017, an estimated $14.1M increase.
  • A.R.T. Advisors's biggest Q4 2017 reduction was AbbVie, cutting an estimated $18.8M.
  • A.R.T. Advisors fully exited Celgene Corp in Q4 2017, selling an estimated $23M.
  • A.R.T. Advisors's ten largest holdings make up 6.6% of its $2.26B portfolio in Q4 2017.
  • A.R.T. Advisors opened 614 new positions and closed 591 in Q4 2017.
  • A.R.T. Advisors's portfolio value rose 15% quarter-over-quarter to $2.26B.

Based on A.R.T. Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.